Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects

NCT01177540 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
25
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated early due to enrollment difficulties and the futility of observing differences in remission rate between treatment arms.

Conditions

Interventions

Sponsor

Eisai Inc.